News and Reports
-
ChemoCentryx's Traficet-EN demonstrates effectiveness in Crohn's disease
7 December 2009Download -
Nereus Pharmaceuticals presents positive study of randomized phase 2 clinical trial of Plinabulin (NPI-2358) in non-small cell lung cancer
23 November 2009Download -
Biovitrum - The creation of a new niche specialty pharmaceutical company focused on rare diseases - with strong cash flow generation and growth potential
5 November 2009Download -
Probiodrug closes series B financing round exceeding Euro 36 million (USD 54 million)
2 November 2009Download -
Nabriva Therapeutics raises Euro 15 million (USD 22 million)
28 October 2009Download -
Asthmatx receives FDA advisory panel recommendation for 'approvable with conditions' for bronchial thermoplasty with the Alair system for severe Asthma
28 October 2009Download -
PTC Therapeutics initiates phase 2 clinical trial of Ataluren (PTC124) in patients with Hemophilia
26 October 2009Download -
Lux Biosciences's potential of LUVENIQ (LX211) as first disease modifying treatment for sight-threatening non-infectious Uveitis highlighted at American Academy of Ophthalmology
26 October 2009Download -
Lux Biosciences completes $50 million series B financing
19 October 2009Download -
Paratek Pharmaceuticals signs worldwide license and commercialization agreement for PTK 0796, broad-spectrum oral and IV antibiotic in phase 3
8 October 2009Download -
mtm laboratories extends series C financing round by EUR 7 million bringing total to EUR 39 million (USD 57 million)
5 October 2009Download -
Sloning closes growth financing round led by LBBW Venture
25 September 2009Download -
Mpex Pharmaceuticals announces positive phase 2b clinical trial results with Aeroquin (MP-376) treatment in Cystic Fibrosis patients
20 September 2009Download -
HBM Partners successful trade sale of Swiss biotech company ESBATech to Alcon
14 September 2009Download -
PTC Therapeutics initiates registration-directed Phase 3 trial of Ataluren in Cystic Fibrosis
10 September 2009Download -
MiCardia announces completion of enrollment in “DYANA” European CE study
4 September 2009Download -
Successful sale of BRAHMS in an all-cash transaction to Thermo Fisher Scientific: Net profit for HBM advised antities of EUR 134.2 million, or 21.6 times the invested equity
3 September 2009Download -
PTC Therapeutics announces achievement of major milestone in Schering- Plough Hepatitis C collaboration
10 August 2009Download -
Zosana Pharma, Inc. secures $30 million in new round of financing
7 July 2009Download -
Brahms - New cardiac marker copeptin accelerates diagnosis of acute myocardial infarction (AMI)
2 July 2009Download -
Sloning BioTechnology and Henkel to cooperate in enzyme development
30 June 2009Download -
Brahms - Cezanne and Lumiphore announces partnership for diagnostic tests
22 June 2009Download -
Vivacta raises $4.5 million to commercialise piezofilm technology
16 June 2009Download -
MiCardia announces first U.S. implant
16 June 2009Download -
Devax receives IDE approval to commence bifurcation stent trial
29 May 2009Download